Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$431K Hold
3,583
0.14% 61
2025
Q4
$377K Buy
3,583
+10
+0.3% +$939 0.12% 63
2025
Q3
$300K Sell
3,573
-8,586
-71% -$707K 0.1% 67
2025
Q2
$962K Sell
12,159
-9,761
-45% -$776K 0.35% 45
2025
Q1
$1.97M Sell
21,920
-6,273
-22% -$586K 0.92% 29
2024
Q4
$2.8M Sell
28,193
-28,307
-50% -$2.92M 1.45% 24
2024
Q3
$6.42M Buy
56,500
+28,308
+100% +$3.36M 1.87% 20
2024
Q2
$3.49M Sell
28,192
-680
-2% -$87.6K 2.17% 19
2024
Q1
$3.81M Buy
28,872
+201
+0.7% +$24.8K 2.31% 18
2023
Q4
$3.13M Sell
28,671
-347
-1% -$36K 1.97% 20
2023
Q3
$2.99M Sell
29,018
-69
-0.2% -$7.44K 2.04% 17
2023
Q2
$3.36M Buy
29,087
+75
+0.3% +$8.52K 2.26% 16
2023
Q1
$3.09M Sell
29,012
-671
-2% -$72.4K 2.24% 16
2022
Q4
$3.29M Sell
29,683
-1,731
-6% -$177K 2.49% 13
2022
Q3
$2.71M Buy
31,414
+881
+3% +$78.6K 2.28% 14
2022
Q2
$2.78M Buy
30,533
+1,269
+4% +$113K 2.23% 14
2022
Q1
$2.4M Buy
29,264
+4,495
+18% +$354K 1.68% 19
2021
Q4
$1.9M Buy
24,769
+14,852
+150% +$1.18M 1.26% 23
2021
Q3
$745K Buy
9,917
+443
+5% +$33.7K 0.55% 47
2021
Q2
$737K Sell
9,474
-389
-4% -$28.9K 0.53% 47
2021
Q1
$726K Buy
9,863
+227
+2% +$16.7K 0.54% 48
2020
Q4
$752K Buy
+9,636
New +$737K 0.61% 46

Other funds holding MRK

Berkeley Inc's MRK Position: Q1 2026 in Review

Berkeley Inc held its Merck (MRK) position steady in Q1 2026 at 3,583 shares worth $431K. The position accounts for 0.14% of the portfolio, ranked #61.

Berkeley Inc first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.42M in Q3 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Berkeley Inc held 3,583 shares of Merck worth $431K as of Q1 2026.
  • Berkeley Inc left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.14% of Berkeley Inc's portfolio in Q1 2026, its #61 holding.
  • Berkeley Inc first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Berkeley Inc's Merck position peaked at $6.42M in Q3 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Berkeley Inc's 13F filing for Q1 2026, filed 24 Apr 2026.